Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.
Polo R, García-Albéniz X, Terán C, Morales M, Rial-Crestelo D, Garcinuño MA, García Del Toro M, Hita C, Gómez-Sirvent JL, Buzón L, Díaz de Santiago A, Arellano JP, Sanz J, Bachiller P, Alfaro EM, Díaz-Brito V, Masiá M, Hernández-Torres A, Guerra JM, Santos J, Arazo P, Muñoz L, Arribas JR, Martínez de Salazar P, Moreno S, Hernán MA, Del Amo J; EPICOS.
Polo R, et al.
Clin Microbiol Infect. 2023 Jan;29(1):85-93. doi: 10.1016/j.cmi.2022.07.006. Epub 2022 Aug 5.
Clin Microbiol Infect. 2023.
PMID: 35940567
Free PMC article.
Clinical Trial.